Cutanos GmbH is a young biotech start-up based in Vienna, Austria, founded in 2021. The company specializes in developing targeted drug delivery systems for the creation of innovative immunotherapies, including anti-viral vaccines and treatments for autoimmune diseases. With a focus on biotechnology, the startup seeks to revolutionize the field of immune modulation. Currently, there is no publicly disclosed information available regarding last investment and last investment investors.
There is no investment information
No recent news or press coverage available for Cutanos GmbH.